Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody levels in cord blood after maternal recombinant acellular pertussis vaccination
TCTR20200528006Completed
- Sponsor
- Chulalongkorn University
- Start
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of acellular pertussis vaccine in pertussis, sponsored by Chulalongkorn University. Primary endpoint: Cord blood pertussis-specific antibody levels. Started Jan 2019; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20200528006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200528006.